Legal Representation
Attorney
Victoria Friedman
USPTO Deadlines
Next Deadline
1740 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240924)
Due Date
September 24, 2030
Grace Period Ends
March 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 26, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jul 7, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jul 7, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Mar 22, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Mar 4, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Mar 4, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Dec 24, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Sep 24, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 24, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 9, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 9, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 19, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 6, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 5, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 5, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 5, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 24, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Apr 2, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Apr 2, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 18, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 17, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 16, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 16, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 12, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 9, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Test paper, chemical; chemical preparations in the nature of filtering materials for use in the manufacture of pharmaceuticals; chemical getters; acid proof chemical compositions for use in the manufacture of pharmaceuticals; antioxidants for use in the manufacture of pharmaceuticals; chemical reagents, other than for medical or veterinary purposes; chemical accelerants; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemicals for scientific use; biochemical catalysts
Class 005
Pharmaceutical preparations for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; chemical preparations for medical purposes, namely, for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; antimicrobials for dermatologic use; nutritive substances for micro-organisms for medical use; sterilizing preparations; medicinal infusions for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; chemical reagents for medical or veterinary purposes
Class 042
Chemical analysis; scientific laboratory services; chemical research; inspection of drugs for quality control purposes; biomedical research services; development of pharmaceutical preparations and pharmaceuticals; research and development services in the field of chemistry; pharmaceutical research
Additional Information
Design Mark
The mark consists of the stylized word "ORBICULE".
Classification
International Classes
001
005
042